DCM Shriram Ltd has successfully commissioned new Aluminium Chloride and Calcium Chloride production lines at its Jhagadia facility. The expansion enhances the company's downstream integration, allowing better utilization of chlorine and hydrochloric acid as raw materials. This move is part of a broader strategy to boost operational flexibility in its chemical division. Investors should keep an eye on the production ramp-up of the new units and the upcoming commissioning of the second Calcium Chloride line scheduled for October 2026.
DCM Shriram Expands Jhagadia Chemical Capacity
Aluminium Chloride capacity hits 250 TPD; new Calcium Chloride line adds 133 TPD to operations.
Reader Takeaway: Improved chlorine value-chain integration offers operational resilience, while successful capacity ramp-up remains the primary growth catalyst.
What just happened
DCM Shriram Ltd has officially commissioned two major chemical plants at its manufacturing site in Jhagadia. The company has brought a new 100 TPD Aluminium Chloride plant online, pushing its total aggregate capacity for the product to 250 TPD. Simultaneously, the company has commissioned the first of two production lines for Calcium Chloride, contributing 133 TPD of capacity. Market acceptance for the newly produced Calcium Chloride has been reported as positive.
Why this matters
This expansion is central to the company’s ongoing downstream integration strategy. By investing in these facilities, DCM Shriram is creating a captive internal market for its primary chlorine production. The Aluminium Chloride facility consumes chlorine directly, while the Calcium Chloride plant utilizes hydrochloric acid, a derivative of the chlorine production process. This vertical integration reduces dependency on external demand for raw chlorine and captures higher margins through value-added chemical products.
Risks to watch
Investors should closely track the operational ramp-up of the new Aluminium Chloride plant, as nominal capacity does not immediately translate to full-scale profitability. Furthermore, the company faces a project execution milestone in October 2026, when the second 133 TPD Calcium Chloride line is scheduled for commissioning. Any technical or logistical delays in this second phase could impact the projected revenue scaling of the chemical segment.
What to track next
The market will be looking for sustained product uptake and the company’s ability to maintain high utilization rates at the Jhagadia site. Performance updates regarding the margin impact of these downstream products will be essential in the upcoming quarterly earnings releases.